阿伐他汀钙
| 英文名 | Atorvastatin calcium salt trihydrate | CAS号 | 134523-03-8 |
| 试剂别名 |
ATORVASTATIN CA; [r-(r*, r*)]-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylaminocarbonyl)-1h-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid calcium salt; 1h-pyrrole-1-heptanoicacid,beta,delta-dihydroxy-2-(4-fluorophenyl)-5-(1-methy calciumsalt(2:1),(r-(r*,r*))-lethyl)-3-phenyl-4-((phenylamino)carbonyl); delta-dihydroxy-2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-betcalci1h-pyrrole-1-heptanoicaci; pd134298-38a; ATORVASTATINCALCUIM; calcium (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-yl-pyrrol-1-yl]-3,5-dihydroxy-heptanoate; 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-calcium salt (2:1), (R-(R*,R*))-; 1H-Pyrrole-1-heptanoic acid; beta,delta-dihydroxy-2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-calcium salt (2:1); (R-(R*,R*))-, Atorvastatin calcium; Atorvastatin calcium (USAN); Atorvastatin calcium salt; Atorvastatin calcium [USAN]; C08078; Calcium (betaR,deltaR)-2-(p-fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoate (1:2); CI-981; D00887; DRG-0321; Lipibec; Lipitor; Lipitor (TN); LS-136974; PD 134298-38A; Prevencor; Sortis; Tahor; Torvast; YM-548; Atorvastatin Calsium
|
分子式 | C33H34FN2O5.1/2Ca.3/2H2O |
| 产品编号 | ad21181 | 分子量 | 604.69 |
| MDL号 | MFCD09752074 |
| 产品名称： | 阿伐他汀钙 |
| 英文名称： | Atorvastatin calcium salt trihydrate |
| 英文别名： | ATORVASTATIN CA; [r-(r*, r*)]-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylaminocarbonyl)-1h-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid calcium salt; 1h-pyrrole-1-heptanoicacid,beta,delta-dihydroxy-2-(4-fluorophenyl)-5-(1-methy calciumsalt(2:1),(r-(r*,r*))-lethyl)-3-phenyl-4-((phenylamino)carbonyl); delta-dihydroxy-2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-betcalci1h-pyrrole-1-heptanoicaci; pd134298-38a; ATORVASTATINCALCUIM; calcium (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-yl-pyrrol-1-yl]-3,5-dihydroxy-heptanoate; 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-calcium salt (2:1), (R-(R*,R*))-; 1H-Pyrrole-1-heptanoic acid; beta,delta-dihydroxy-2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-calcium salt (2:1); (R-(R*,R*))-, Atorvastatin calcium; Atorvastatin calcium (USAN); Atorvastatin calcium salt; Atorvastatin calcium [USAN]; C08078; Calcium (betaR,deltaR)-2-(p-fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoate (1:2); CI-981; D00887; DRG-0321; Lipibec; Lipitor; Lipitor (TN); LS-136974; PD 134298-38A; Prevencor; Sortis; Tahor; Torvast; YM-548; Atorvastatin Calsium |
| 中文别名： | 相关CAS号：134523-00-5 |
| CAS No.： | 134523-03-8 |
| 分子式： | C33H34FN2O5.1/2CA.3/2H2O |
| 分子量： | 604.69 |
| 危险品级别： | |
| HS符号： | |
| 危害声明： |
